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Abstract
During analysis of retrospective community survey data, we identified two patients from Xiji
County, south Ningxia Hui Autonomous Region with simultaneous echinococcosis and
tuberculosis (TB), representing the first such reports for China. As the echinococcosis chronicity
increased, the immune profile in both subjects changed from a Th1 to Th2 response, as shown by
a TB skin test, originally positive, becoming negative. Such an elevated Th2 immune profile, with
subsequent suppression of the Th1 immune response, is a common feature of chronic helminth
infections. Given the difficulties in definitive diagnosis, and the potential increased susceptibility for
TB infection in patients with advanced echinococcosis, we suggest that combined TB/
echinococcosis surveys be undertaken in this area in the future. This would allow early diagnosis
of both TB and echinococcosis cases with better prognosis for effective and sustainable treatment
outcomes, ultimately reducing associated morbidity and mortality, and also the overall financial
costs to the individual and the public health care system in this under developed part of China.
Findings
Tuberculosis (TB) affects over five million people in
China, 80 percent living in rural areas [1]. Community
surveys in 1988-89 in rural townships of Xiji County in
south Ningxia Hui Autonomous Region (NHAR), north-
west China indicated a TB prevalence ranging from 0.6-
12.4% (mean 2.2%) [2]. Helminthiases are also extremely
common in China [3]. In Xiji, the prevalence of echinoc-
occosis ranges from 0-7.4% (mean 2%) and from 1-8.1%
(mean 2.5%) for the cystic (CE) and alveolar AE forms,
respectively [4]. Given the similarities in their morbidi-
ties, specific diagnosis of TB and echinococcosis in co-
infected individuals is difficult which may account for the
limited number of reports of simultaneous infections glo-
bally [5].
Retrospective community survey data for TB and echinoc-
occosis [2,4] revealed co-endemic TB and echinococcosis
in a number of townships within Xiji County. The range
of TB prevalence (0.6-12.4%) in the TB/echinococcosis
co-endemic townships was similar to that of the entire
county [2] but the mean prevalence (3.9% v 2.2%) was
significantly higher (Chi-square; P = 0.036). Prevalence of
echinococcosis in the townships ranged from 0.8%-9%
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(mean 4.5%). It is noteworthy that while the surveys were
up to 15 years apart, the incubation period for AE/CE is
10-15 years [6] and so primary Mycobacterium tuberculosis
and Echinococcus infections would have been occurring at
the same time.
We describe two survey subjects with simultaneous echi-
nococcosis and TB, representing the first such reports for
China. Both subjects indicated by questionnaire having
received Bacillus Calmette-Guerrin (BCG) vaccination
during childhood, confirmed by a characteristic raised
skin vaccination scar. Approval for the surveys was given
by the Ethics Committee of Ningxia Medical College; writ-
ten consent to participate was obtained from both
patients.
The first, an 18-year-old male reported to Xiji County
Hospital in 2006 with malaise, weakness, fatigue and a
minor cough. Ultrasound (US) and Computed Tomogra-
phy (CT) scans identified an uneven hypo-echo image
with two irregular lesions in the right liver suggestive of P3
stage AE [6] (Fig. 1.1a). Chest x-ray images showed a
number of small shadows scattered on both sides of his
lungs, the largest being in the lower lobe of the left lung;
CT scans showed a defined edge (Fig. 1.1c &1.1d), possi-
bly a CE lesion. Further US and serology (highly positive
for anti-Em18 antibodies [7]) confirmed P3 stage AE in
the liver with possible metastasis to the lungs. He was pre-
scribed albendazole (ABZ) (10 mg/kg/day) and advised to
attend the annual clinical follow-up thereafter.
The patient had been previously diagnosed with pulmo-
nary TB by chest x-ray in 2000; he had a positive tubercu-
lin skin test and acid fast bacilli were present in his
sputum. Clearly, the earlier BCG vaccination did not pro-
tect. A routine clinical examination in 2003 indicated that
the TB had been cured following three years of regular TB
chemotherapy [8]. X-rays taken in 2006 during the Xiji
County Hospital visit were inconclusive and further tests
to assess TB status were undertaken. A negative tuberculin
skin test and sputum test ruled out relapsed TB. At follow-
up in 2008, the tuberculin skin test had reverted, becom-
ing positive. CT scans of the liver showed that the AE
lesion had shrunk markedly in size (Fig. 1.1b) indicating
effective ABZ treatment. Serology was marginally positive
for anti-Em18 antibodies. A CT scan of the chest showed
a fibre-like scar in the middle right lung and a calcified
lymph node in the middle right hilum (Fig. 1.1e). Moreo-
ver, the lesion was irregular, with greater density (Fig. 1.1e
and 1.1f) compared with the 2006 CT scan (Fig. 1.1c and
1.1d). The clinical diagnosis was confirmed CE in the lung
and effective ABZ treatment.
The second subject was a 36 year-old female referred to
Ningxia Teaching Hospital, Yinchuan city in 2003 com-
plaining of constant abdominal pain. Her BCG vaccina-
tion had not been protective as chest X-rays in 1998
showed TB lesions on both lungs and she had a positive
tuberculin skin test but negative TB sputum test. Despite
having been prescribed TB drugs [8], that she had taken
intermittently, there were concerns that the TB had
invaded her abdomen. X-rays of the chest and abdomen
were normal and the tuberculin skin and sputum tests
were negative. Abdominal CT (Fig. 1.2a) indicated an
advanced stage (P4) liver AE lesion with vascular and bil-
iary involvement of the right liver, with scattered calcifica-
tions within the lesion. Serology [7] for anti-EgB, but not
anti-Em18, antibodies, was positive. She was prescribed
ABZ and followed-up annually by US and questionnaire
examination [4].
In 2005, questionnaire analysis revealed she had two
recent episodes of severe coughing with mucus and white
gelatinous membranous materials expelled, the first in
late 2004 following 18 months of ABZ treatment and the
second in the spring of 2005. Microscopic examination
after the second episode showed the presence of CE-lami-
nated-membranes [9]. The patient was thus diagnosed
with simultaneous AE and CE. Continuous ABZ was pre-
scribed with annual follow-up to monitor treatment effi-
cacy.
Chest CT scans in 2008 showed scars on the top and mid-
dle lobes of both sides of the lung, calcification on both
sides of their related hilar lymph nodes (Fig. 1.2c), and a
5 × 1.5 cm density tissue scar in the lower right lobe (Fig.
1.2d), indicating ABZ had affected the CE lesion. A liver
CT scan showed the same AE lesion (Fig. 1.2b) recorded
in 2003 (Fig. 1.2a), with marginally fewer liquefaction
areas than before, indicating ABZ had had limited effect.
Em18 serology and the tuberculin skin and sputum tests
for TB were negative.
These are the first cases of simultaneous TB and echinoc-
occosis reported in China; both patients presented with
simultaneous AE and CE as well, a feature not uncommon
for NHAR [10]. The significantly increased TB prevalence
in residents of Xiji townships co-endemic for TB and echi-
nococcosis compared with those from townships endemic
only for TB, suggested the increase may be due to co-infec-
tion with Echinococcus.
As the echinococcosis chronicity increased in the two
patients (following the latency period after ingestion of
Echinococcus  eggs), the immune profile appeared to
change from a Th1 to Th2 response, reflected by the posi-
tive tuberculin skin test becoming negative. This corre-
sponded mainly with the progression of AE from early (P1
& P2) to advanced (P3 & P4) stage disease [6], as the infil-
trative growth of an AE lesion releases considerably moreParasites & Vectors 2009, 2:53 http://www.parasitesandvectors.com/content/2/1/53
Page 3 of 5
(page number not for citation purposes)
Figure 1 (see legend on next page)Parasites & Vectors 2009, 2:53 http://www.parasitesandvectors.com/content/2/1/53
Page 4 of 5
(page number not for citation purposes)
parasite antigen constantly stimulating the host immune
system [6]. An elevated Th2 immune profile and subse-
quent suppression of the Th1 immune response is com-
mon in helminth infections [11]. With a suppressed Th1
immune profile the hosts' ability to detect and respond to
viruses, bacteria and other pathogens is impaired [12] and
Th1-based vaccines can become ineffective.
Despite BCG vaccination, both subjects developed TB and
were skin-test-positive. Following TB treatment, they
developed non-specific symptoms resembling a relapsed
TB infection; however both cases then became skin test-
negative and were subsequently diagnosed with advanced
stage (P3 or P4) AE. Given the length of the incubation
period of an Echinococcus infection, it is most likely that
the cases were infected prior to contracting TB.
Albendazole can vary in its efficacy against echinococco-
sis, particularly AE [6], exemplified by these two patients.
In the first, treatment was effective as shown in 2008 by
CT scans of the liver showing regression of the AE lesion,
with his immune profile reverting to Th1 as shown by the
tuberculin skin test reverting to positive. In contrast, treat-
ment of the female subject was largely ineffectual; the
large AE lesion showed no reduction in size and the tuber-
culin test remained negative.
Similarities in the symptoms of TB and echinococcosis
and the immune progression of both diseases make their
definitive diagnosis difficult. A TB infection can often
mask the symptoms of early stage echinococcosis, partic-
ularly pulmonary echinococcosis. Suppression of the
immune system can then promote the progression to later
stage echinococcosis or secondary metastases in the case
of AE. Moreover, subjects with advanced stage echinococ-
cosis have a pronounced Th2 immune profile [11], mir-
rored in both study subjects by their negative tuberculin
skin test. A previous report of helminth infected Ethiopian
immigrants showed they responded poorly to skin testing
for TB compared with immigrants who had been de-
wormed [13] indicating that this immune modulation
may compromise the diagnostic efficacy of the tuberculin
skin test. Further, studies have also shown that severe AE
or CE cases exhibit poor lymphocyte responses both in
vivo and in vitro with the Th1 immune response being
strongly suppressed in patients with advanced disease
[12,14].
A recent study has suggested a mechanism whereby con-
comitant systemic helminth infections predispose to the
development of active tuberculosis in humans [15]. By
analysing the cellular responses to mycobacterial antigens
in patients who had latent tuberculosis with or without
filarial infection, the study demonstrated that filarial
infection coincident with M. tuberculosis infection signifi-
cantly diminishes M. tuberculosis-specific Th1 (interleukin
[IL]-12 and IFN-gamma) and type 17 T helper (Th17; IL-
23 and IL-17) responses related to increased expression of
cytotoxic T lymphocyte antigen (CTLA)-4 and pro-
grammed death (PD)-1. These findings reinforce our ear-
lier comments regarding vaccine use in helminth -
endemic countries in that those requiring a Th1 or Th17
response for efficacy may not function optimally in the
presence of a chronic helminth coinfection.
Xiji County is underdeveloped and poor and the local
hospitals generally lack adequate facilities and technical
expertise, with laboratory diagnosis often unhelpful. The
majority of TB cases are usually diagnosed by clinical fea-
tures, exposure history, a positive tuberculin test and the
presence of bacteria in sputum by microscopy. This latter
method is rapid, but it is relatively insensitive if insuffi-
cient sputum is provided, or if few bacteria are present
[16]. Given there is co-endemic TB and echinococcosis in
Xiji, the difficulties in definitive diagnosis, and the poten-
tial increased susceptibility for TB infection in patients
with advanced echinococcosis, we suggest that combined
TB/echinococcosis surveys be undertaken in this area in
the future. This would allow early diagnosis of both TB
and echinococcosis cases with better prognosis for effec-
tive and sustainable treatment outcomes, ultimately
reducing associated morbidity and mortality, and also the
overall financial costs to the individual and the public
health care system in this under developed part of China.
CT scans of patient 1 (18-year-old male) (panels 1a-f) and patient 2 (36 year-old female) (panels 2a-d) Figure 1 (see previous page)
CT scans of patient 1 (18-year-old male) (panels 1a-f) and patient 2 (36 year-old female) (panels 2a-d). Panel 1a 
shows the liver in 2006 showing two irregular lesions located in the right lobe with scattered calcifications. Panel 1b is a follow-
up scan of the liver taken in 2008 showing that the lesions had shrunk in size after treatment with albendazole. Panels 1c and 1d 
show the lung in 2006 having a lesion with the density of liquid, a clear edge, and surrounding inflammatory infiltrate extending 
to the anterior pleura. Panels 1e and 1f are follow-up lung CT scans taken in 2008 showing the lesion had shrunk in size. Panel 
2a shows the liver in 2003 with a large irregular lesion located in the right lobe having scattered calcifications and liquefactions 
within it. Panel 2b shows the liver in 2008 indicating that the same lesion had not changed in size but with increased calcifica-
tion and decreased liquefaction areas present. Panels 2c and 2d show the lung in 2008. Panel 2c shows a number of calcified 
lymph nodes on both sides of the upper and middle lung hila (indicating previously active TB). Panel 2d shows scar tissue 
(approximately 1.5 × 5 cm) in the right lower lobe of the lung without related lymph node calcification.Publish with BioMed Central    and   every 
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